Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Peripheral T-Cell Lymphoma Clinical Trials
Peripheral T-Cell Lymphoma clinical trials are recruiting across 48 cities. Here are the cities with the most active studies:
Peripheral T-Cell Lymphoma Trial Phases
18 research organizations are sponsoring peripheral t-cell lymphoma trials.
About Peripheral T-Cell Lymphoma
Peripheral T-cell lymphomas are a diverse group of aggressive non-Hodgkin lymphomas that develop from mature T-cells. They account for about 10-15% of all NHL cases. Treatment includes combination chemotherapy, stem cell transplant, and newer targeted agents.
Clinical trials are advancing new treatments for peripheral t-cell lymphoma. Currently, 22 studies are recruiting a combined 3,283 participants across the United States. Research is being conducted by 18 organizations including Memorial Sloan Kettering Cancer Center, Associazione Angela Serra per la ricerca sul cancro, Eastern Cooperative Oncology Group and 15 others.
2026 Peripheral T-Cell Lymphoma Research Landscape
As of July 2026, the peripheral t-cell lymphoma clinical trial landscape includes 22 actively recruiting studies across 48 cities in the United States. These studies are collectively seeking 3,283 participants, with an average enrollment target of 149 per study.
The research spans multiple phases of development: 9 studies are in PHASE2, 8 studies are in PHASE1, 2 studies are in PHASE3, 1 study is in NA. The presence of Phase 3 trials indicates that some peripheral t-cell lymphoma treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 18 different organizations, including Memorial Sloan Kettering Cancer Center, Associazione Angela Serra per la ricerca sul cancro, Eastern Cooperative Oncology Group, University of Pittsburgh, Corvus Pharmaceuticals, Inc., and 13 others. The large number of sponsors reflects significant research interest and investment in peripheral t-cell lymphoma treatment advancement.
Geographically, peripheral t-cell lymphoma trials are most concentrated in Duarte, California (7 trials); New York, New York (7 trials); Boston, Massachusetts (5 trials); New Haven, Connecticut (4 trials); Miami, Florida (4 trials) and 7 other cities.
Featured Peripheral T-Cell Lymphoma Studies
Highlighted recruiting studies for peripheral t-cell lymphoma, selected by enrollment size and research scope.
A Registry for People With T-cell Lymphoma
The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.
Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
This study T-Cell Project 2.0 is based on the former International PTCL study designed by the International T-cell Non-Hodgkin's Lymphoma Study Group (T-Cell Project 1.0: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma) as a prospective collection of data to predict the prognosis of patients with the more frequent subtypes of PTCL. It is a prospective, longitudinal, inte...
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with peripheral T-cell lymphoma who achieved a complete response after initial chemotherapy. Usual treatment after a complete response may include observation or high dose chemotherapy followed by an autologous stem cell transplant, however, it is not kno...
Frequently Asked Questions About Peripheral T-Cell Lymphoma Clinical Trials
Are there peripheral t-cell lymphoma clinical trials near me?
Yes, there are 22 peripheral t-cell lymphoma clinical trials currently recruiting across 48+ cities in the United States, including Duarte, California; New York, New York; Boston, Massachusetts. Browse the studies above to find one at a location convenient for you.
How do I join a peripheral t-cell lymphoma clinical trial?
To join a peripheral t-cell lymphoma clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are peripheral t-cell lymphoma clinical trials free?
Yes, participation in peripheral t-cell lymphoma clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of peripheral t-cell lymphoma treatments are being studied?
Current peripheral t-cell lymphoma clinical trials are testing a range of approaches across PHASE2 (9 studies), PHASE1 (8 studies), PHASE3 (2 studies), NA (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 18 research organizations.
Is it safe to participate in peripheral t-cell lymphoma clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 15, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 15, 2026 · Data from ClinicalTrials.gov